2,3-naphthalenedicarboxaldehyde has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Linz, TH; Lunte, SM; Snyder, CM | 1 |
| Bonfigli, AR; Coppa, G; Gambini, A; Marra, M; Testa, I; Testa, R | 1 |
2 other study(ies) available for 2,3-naphthalenedicarboxaldehyde and Cardiovascular Diseases
| Article | Year |
|---|---|
Optimization of the separation of NDA-derivatized methylarginines by capillary and microchip electrophoresis.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Electrophoresis, Capillary; Electrophoresis, Microchip; Humans; Lasers; Naphthalenes; Prognosis | 2012 |
High-performance liquid chromatographic assay of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine in human plasma by derivatization with naphthalene-2,3-dicarboxaldehyde.
Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Naphthalenes; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence; Stereoisomerism | 2003 |